200 jobs in Alexion expansion
A leading bio-pharmaceutical firm which focuses on treatments for severe and rare disorders is to create about 200 jobs.
Alexion Pharmaceuticals will expand its Irish operations in a 450 million euro project over the next four years at its College Park site in Blanchardstown, Dublin which will take its workforce to almost 500.
The new facility will be the company's first biologics manufacturing facility outside the United States, which uses human genes to create proteins.
Tanaiste Joan Burton attended the announcement and said it underlines the jobs-led recovery is under way.
"Alexion's latest expansion is an extremely strong endorsement for Ireland, and Dublin West in particular, as an attractive location for high-end investment from the pharmaceutical industry," she said.
Since setting up in Ireland in 2013, Alexion has invested 130m euro in two facilities - a plant in Athlone and a supply centre in Blanchardstown with laboratories, packaging and warehousing.
About 800 construction workers will be employed on the expansion of the College Park site.